Back to Awarded Treatment Trials
Awarded Trial: 12T-002
Grant ID
12T-002
Illness
schizophrenia
Primary Drug/Intervention
Cholecalciferol (vitamin D-3)
Primary Dosage
4000 IU/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Clelland
Sample Size
80
Duration of Study Period for Each Subject
70 days
Outcome Measurements
N/A
Results
Study was cancelled because of lack of study sites with sufficient patient numbers
Publication
N/A
Link
N/A
PI Name
James Clelland
Degree
PhD
Center
Langone Medical Center
Institution
New York University
Address
550 1st Avenue
City or Town
New York
State or Province
NY
Zip or Postal Code
10016
Country
USA
Email Address
jc150@nyu.edu